Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
Public ClinicalTrials.gov record NCT00431444. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Double-dummy Study in Postmenopausal Women With Low Bone Mineral Density to Compare the Effects of a Single Dose of i.v. Zoledronic Acid 5 mg, With Daily Oral Raloxifene 60 mg OD on Bone Turnover Markers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the effects of Zoledronic acid and Raloxifene in reducing bone turnover markers in postmenopausal women with low bone mineral density over 6 months.
Study identification
- NCT ID
- NCT00431444
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- Raloxifene Drug
- Zoledronic acid Drug
- Placebo oral pills Drug
- Placebo intravenous (i.v.) infusion Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2007 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Jul 2008 (Actual)
- Last update posted
- Mar 29, 2011
2007 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Women's Health Research | Phoenix | Arizona | 85015 | — |
| Associated Pharma Research Center | Buena Park | California | 90620 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Women's Physicians of Jacksonville | Jacksonville | Florida | 32256 | — |
| Tampa Clinical Research | Tampa | Florida | 33624 | — |
| Springfield Clinic | Springfield | Illinois | 62703 | — |
| Consultants in Women's Health Care | St Louis | Missouri | 63131 | — |
| Alegent Health | Omaha | Nebraska | 68152 | — |
| Specialty Medical and Research Center | Pahrump | Nevada | 89048 | — |
| UMDNJ-Robert Wood Johnson Medical Center | New Brunswick | New Jersey | 08901 | — |
| Columbia University | New York | New York | 10032 | — |
| Kernodle Clinic, Inc. | Burlington | North Carolina | 27215 | — |
| The Portland Clinic | Portland | Oregon | 97205 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Texas Institute for Clinical Research | Fort Worth | Texas | 76104 | — |
| Valley Women's Health Clinic | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00431444, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2011 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00431444 live on ClinicalTrials.gov.